Evaluation of the economic burden of Herpes Zoster (HZ) infection. - Wikidata - awgldk - TriplyDB

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

http://www.wikidata.org/entity/Q35498396

about

How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States.Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster.Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States.Advances in our understanding of immunization and vaccines for patients with systemic lupus erythematosus.Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan.A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

P2860

Q36580689-6455DC68-8901-4C2B-8278-26C32CA74CAB Q37091674-721BF387-1BB2-46CE-A5C4-208B0B21C5AA Q37383627-99E0F92F-4383-45BE-B4BC-C266BE5FA5AE Q38375698-97983EC0-AB43-41CC-A84A-DD323C3B6A9C Q40106216-4898F612-D791-451A-94D8-C5A105775F0D Q47116379-3DD32FDD-3821-4588-9B59-E71DB6DAC31A Q56888201-F657675C-C605-46C3-A08D-79B867DC214D

P2860

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

http://www.wikidata.org/entity/Q35498396

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

@ast

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

@en

type

label

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

@ast

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

@en

prefLabel

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

@ast

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

@en

P1433

Q35498396-E14ABBDD-C378-49D5-B4FD-9932F48DF72C

P1476

Q35498396-56E31DBB-65C0-400D-BFE2-B921A57738BA

P2093

Q35498396-03E169F4-F758-4D16-8811-50125777D038

Q35498396-1F9C92B8-DF41-4854-B6E2-6AA2C370723B

Q35498396-2753B24D-28F0-4099-9247-8B44BFE5EE52

Q35498396-6B30C186-80C1-4EB1-A2FF-C8DDAC3F5AA7

Q35498396-85670925-7F9F-43F2-9B7B-FF0EE92BF680

Q35498396-9B4E33DF-E7D7-40B1-96E4-EE1DDA7567F9

P2860

Q35498396-00916E08-8240-46E1-9ADE-091F0472E7A9

Q35498396-0302FB3F-5636-4D07-96ED-B6CE64C8D359

Q35498396-06172298-44F3-4AC8-91DE-5C612B3D9815

Q35498396-069972A9-2D34-4D34-83BE-61A7CB6754D7

Q35498396-06D96A30-4F1D-475F-916B-5CFE464D1170

Q35498396-070E24D9-1521-4482-893F-F620A1418E00

Q35498396-0E73B7C9-9622-48B1-ABA1-BB7B2D01A2E5

Q35498396-0FBE581A-C5A0-4911-9AFC-86E249464564

Q35498396-113905E6-9EF2-4000-8CF1-EEFA77134181

Q35498396-18963B4C-E6B1-40D6-81CD-B4C9633498E4

P304

Q35498396-20C25D1E-1AAA-421B-9987-082FD11AA3BA

P31

Q35498396-982DC1BA-356F-469A-AE6F-FDBA433026A1

P356

Q35498396-D3432AAB-AAE6-469D-A30E-7482578C3C18

P433

Q35498396-C7C2A04D-3D84-4D2C-B9E4-C3B1928B4F5E

P478

Q35498396-73F5059C-DA45-4D71-B3D3-1AF1F01FBF7D

P50

Q35498396-DD8FEED7-56D0-4D00-BCCD-4CD165280D59

Q35498396-EE544075-C52C-489C-AD6A-0623B66089BE

P577

Q35498396-9C5DC2FA-1B63-4686-971F-F9B7A69099FB

P5875

Q35498396-271023D9-EABF-49D0-9667-E695BF52301B

P698

Q35498396-3E137D8F-11B8-45A0-B31D-FC98A500DB4C

P932

Q35498396-3C2A9C7C-9830-48BE-A1E1-C2A5F0326F81

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

@en

P2093

Daniela Amicizia

http://www.w3.org/2001/XMLSchema#string

Emanuela Rizzitelli

http://www.w3.org/2001/XMLSchema#string

Giancarlo Icardi

http://www.w3.org/2001/XMLSchema#string

Paolo Bonanni

http://www.w3.org/2001/XMLSchema#string

Roberto Gasparini

http://www.w3.org/2001/XMLSchema#string

Sara Boccalini

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia

THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS

Similar herpes zoster incidence across Europe: results from a systematic literature review

Varicella zoster virus (VZV)-human neuron interaction

What does epidemiology tell us about risk factors for herpes zoster?

Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States

Herpesviruses: latency and reactivation - viral strategies and host response

Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data.

Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination.

P304

245-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.36160

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Nicola Luigi Bragazzi

Donatella Panatto

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269284469

http://www.w3.org/2001/XMLSchema#string

P698

25483704

http://www.w3.org/2001/XMLSchema#string

P932

4514227

http://www.w3.org/2001/XMLSchema#string